6.47
price down icon1.97%   -0.13
after-market Dopo l'orario di chiusura: 6.50 0.03 +0.46%
loading

Capricor Therapeutics Inc Azioni (CAPR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 11.13 2.2616 3.9714
Operating Expenses
10.95%
27.72
24.98 18.83 15.27 15.56
Operating Income/Loss
10.95%
-27.72
-24.98 -7.6978 -13.01 -11.59
Nonoperating Income/Loss
205.80%
1.8083
0.5914 0.5812 0.4532 0.5914
Income/Loss From Continuing Operations Before Tax
6.23%
-25.91
-24.39 -7.1166 2.2616 -11.00
Income/Loss From Continuing Operations After Tax
6.23%
-25.91
-24.39 -7.1166 -12.56 -11.00
Net Income/Loss
6.23%
-25.91
-24.39 -7.1166 -12.56 -11.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.16%
45.71
45.64 3.1194 33.09 31.84
Diluted Average Shares
0.16%
45.71
45.64 3.1194 33.09 31.84
Basic Earnings Per Share
7.55%
-0.57
-0.53 -0.11 -0.38 -0.35
Diluted Earnings Per Share
7.55%
-0.57
-0.53 -0.11 -0.38 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Capitalizzazione:     |  Volume (24 ore):